Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016
Abstract Major advances have been made in the treatment of cancer with targeted therapy and immunotherapy; several FDA-approved agents with associated improvement of 1-year survival rates became available for stage IV melanoma patients. Before 2010, the 1-year survival were quite low, at 30%; in 201...
Main Authors: | Paolo A. Ascierto, Sanjiv S. Agarwala, Gennaro Ciliberto, Sandra Demaria, Reinhard Dummer, Connie P. M. Duong, Soldano Ferrone, Silvia C. Formenti, Claus Garbe, Ruth Halaban, Samir Khleif, Jason J. Luke, Lluis M. Mir, Willem W. Overwijk, Michael Postow, Igor Puzanov, Paul Sondel, Janis M. Taube, Per Thor Straten, David F. Stroncek, Jennifer A. Wargo, Hassane Zarour, Magdalena Thurin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-017-1341-2 |
Similar Items
-
Future perspectives in melanoma research
by: Paolo A. Ascierto, et al.
Published: (2016-11-01) -
Perspectives in melanoma: meeting report from the “Melanoma Bridge” (December 5th–7th, 2019, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2020-09-01) -
Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November–2 December, 2017, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2018-07-01) -
The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017
by: Paolo A. Ascierto, et al.
Published: (2018-04-01) -
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
by: Paolo A. Ascierto, et al.
Published: (2019-07-01)